Virscio is a enabling development of advanced medicines through the integration and application of next generation in vivo models, technologies, and preclinical capabilities. 

The world is entering the next industrial revolution - and it is being driven by innovations in biology, research tools, and technologies that are expanding our understanding of human biology and disease pathology at an exponential rate.   While greater biological insights are a fundamental building block for defining and testing new hypotheses that might yield new treatments for patients in need, clinical success will hinge critically on the ability to design and test novel therapeutic approaches in clinically relevant models. 

At Virscio, we believe 

Our team is passionate about impacting human health through the development and application of models,  to address major human health challenges. We are at the forefront of reducing translational risks by leveraging the latest insights in human pathophysiology. This knowledge guides us in developing and refining predictive preclinical models that accurately mirror human disease and therapeutic interventions.

Our approach to these complex challenges is defined by unmatched preclinical expertise and capabilities. We offer:

• Expert knowledge across various therapeutic areas.
• Industry-leading efficiency in project initiation and data delivery.
• Customized, hands-on involvement aligned with specific goals.
• A commitment to producing clear, actionable results and conclusions.
• A comprehensive range of proven efficacy and safety models and delivery techniques.
• Ethical and sustainable access to a large, biologically pristine nonhuman primate population.